Search Results

Southwestern Medical Center with Bruce Horazdovsky, Ph.D. the faculty in the Department of Pharmacology and Physiology at the University of Rochester Medical Center

This session addresses the structural and strategic decisions that determine whether breakthrough science He also serves as Director of the Advanced Research Centre at the University of Glasgow, a £130M collaborative His recent work on muscarinic acetylcholine receptor modulation and structure-guided design of M1 receptor

Technology in Genova, Italy (2008-2016) and an Associate Research Professor in the Department of Cell Biology Before joining the Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000

workflows, accelerate discovery, and drive breakthroughs in drug development, diagnostics, and disease biology receptors in primary cells View Product The Fab Anti-Mouse IgG2 Eu-conjugate is suited to study mouse biologics Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University Internalization is a core—but often overlooked—dimension of GPCR biology.

Discovering these receptors would be a significant breakthrough in cardiovascular biology as they could My long-term plan is to conduct research in the field of receptor biology, with a focus on GPCRs.

Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain and Belgium, and subsequently as a cell biologist during my postdoc (2006-2011) with Dr. Marilyn Farquhar (UC, San Diego), a pioneer of modern Cell Biology. To achieve this goal, we use a wide range of established approaches (biochemistry, cell biology, genetics

Companies present their services in a structured format so GPCR discovery teams can quickly identify Your structured home within the ecosystem The GPCR CRO Bank is a strong fit for companies that want to : Make their services or products easily discoverable within the GPCR ecosystem Present clear, structured

Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR biology protease-activated receptors, particularly PAR1, and over the years she has discovered novel aspects of GPCR biology

Kaavya Krishna Kumar on the web Journal of Biology Chemistry Stanford University Google Scholar LinkedIn

Slosky was awarded a B.S. with honors in Molecular and Cellular Biology and Psychology from The University Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab

Signaling Kinetics Shapes GPCR Drug Action Sam Hoare Watch Now The Spatiotemporal Revolution in GPCR Biology University helps you understand and apply that knowledge — through expert context, structured scientific The classes are designed for researchers, students, and professionals in biology, pharmacology, and biochemistry

Bouvier toward the sympathetic nervous system, the postdoc in Bob Lefkowitz's lab during the molecular biology unexpected data and what it signals about discovery 14:49 Arriving at Duke during the GPCR molecular biology able to work with him and his team and use the tools developed in his lab to better understand GPCR structure

Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center

prestigious venue, CINVESTAV - Centro de Investigación y de Estudios Avanzados del IPN (in English: Center

Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical Biology

upcoming GPCR Masterclass live sessions featuring expert discussions on GPCR pharmacology, receptor biology Tobin How to Build Breakthrough GPCR Programs Sudarshan Rajagopal The Spatiotemporal Revolution in GPCR Biology GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor biology

the functional diversity of bitter taste receptors means for novel therapeutic targets beyond sensory biology receptor regulation—work that sparked his ongoing engagement with receptor signaling and microdomain biology

While in San Francisco, I completed Startup101 - a course a offered by the entrepreneurship center.

Nigel Bunnett at the NYU Pain Research Center as a postdoctoral researcher. Badr recounting his journey from struggling with math in an engineering physics degree to excelling in biology

where he is currently a practicing molecular pharmacologist and biophysicist, systems and synthetic biologist , technologist, heavy CRISPR user, protein sequence- and structure-based informaticist, computational

broad questions in pharmacology, with a specific focus on G-protein coupled receptor signaling and biology

Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors

. 🧭 Full-Length Course Structure: 4 × 1-hour sessions Purpose: Deep, multi-session learning experience Best for: Comprehensive topics that require exploration and discussion ⚡ Short Course Structure: 1 session coverage of key concepts Best for: Core methods, applied principles, or emerging topics 🔍 Mini Course Structure instructor agreement (you’ll receive the full version right after submission). 🧱 Step 2: Plan Your Course Structure

Hicks About Chloe Hicks Chloe Hicks will graduate from Duke University this spring with a B.S degree in Biology

Gabriele Kockelkoren About Gabriele Kockelkoren I have a strong background in both physics and molecular biology

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD

Her work involves the pharmacological and structural characterisation of novel putative antipsychotic

objectives ✅ Build internal systems and workflows that support scale ✅ Create investor-ready operating structures It is the nature of scientific possibility. 👉 The problem begins when ambition grows faster than structure

Gasser " I received my BS and MS in Zoology & Physiology at the University of Wyoming, where I studied I received my PhD in Biology at Arizona State University, where I worked in the lab of Miles Orchinik

His doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.